Longitude Capital — 2023 Investments
2 investments dated 2023 · listed companies and verified rows first · show all
BiotechMenlo Park, US
Mani Subramanian(Executive Officer, Director)Gangadhara Ganapati(Executive Officer, Director)
BoardMatthew Young(Director)inSrinivas Akkaraju(Director)Cory Freedland(Director)Edward Fleming(Director)
Co-investorsSamsara BioCapitalAscenta Capital
Quanta is a biotech company developing orally bioavailable, CNS-penetrant small-molecule KRAS inhibitors targeting RAS-driven cancers such as pancreatic, colorectal, lung, and endometrial cancers.
BiotechDeep TechHealthtechSouth San Francisco, US
Cameron Pitt(Executive Officer, Director)Ying Huang(Director)Derek Metzger(Executive Officer)
BoardMaha Katabi(Director)Perry Nisen(Executive Officer, Director)Maria Fardis(Director)
Co-investorsSofinnova VenturesVida VenturesBiotechnology Value FundFrazier Life Sciences
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.